Aplagon

Biotechnology Research • Tukholmankatu 8A, Helsinki, Finland • 1-10 Employees

Company overview

Headquarters	Tukholmankatu 8A, Helsinki, 00250, FI
Phone number	+358407625159
Website	aplagon.com
NAICS	541714
SIC	283
Keywords	Clinical Trials, Life Sciences, Healthcare Solutions, Drug Development, Medical Research, Pharmaceutical Development, Cardiovascular Disease Research, Peripheral Arterial Disease, Biopharmaceutical Research, Biotechnology Innovations, Apac Therapeutics, Antiplatelet And Anticoagulant Research, Antithrombotic Therapies, Clinical-Stage Biopharmaceuticals, Critical Limb Ischemia Treatment, Hemodialysis Access Failure Prevention, Thromboinflammatory Diseases, Vascular Inflammation, Vascular Surgery Innovations
Founded	2009
Employees	1-10
Socials

Key Contact at Aplagon

Jarna Hannukainen

Clinical Study Director

Aplagon Email Formats

Aplagon uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@aplagon.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@aplagon.com	100%

About Aplagon

Founded on pioneering research by Riitta Lassila and associates at the Wihuri Research Institute in Helsinki, Aplagon is a clinical-stage biopharmaceutical company dedicated to developing first-in-class therapeutics for thromboinflammatory diseases, addressing critical unmet medical needs in vascular medicine. Its lead therapeutic, APAC, a heparin proteoglycan mimetic, is a dual AntiPlatelet and AntiCoagulant (APAC) with unique antithrombotic and anti-inflammatory properties. Designed to specifically target vascular injury sites, APAC provides localized, long-term action while minimizing systemic exposure. The company’s clinical pipeline focuses on addressing thromboinflammatory conditions, with lead indications in arteriovenous fistula (AVF) maturation failure for hemodialysis patients and chronic limb threatening ischemia (CLTI) to prevent amputations and major cardiovascular events.

Aplagon revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Director

Funding Data

Aplagon has never raised funding before.

Aplagon Tech Stack

Discover the technologies and tools that power Aplagon's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Debian

Operating systems

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Google PageSpeed

Caching

Lightbox

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Google Maps

Maps

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

Aplagon is located in Tukholmankatu 8A, Helsinki, FI.

You can reach Aplagon at +358407625159.

Aplagon was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Aplagon has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Aplagon

Jarna Hannukainen

Clinical Study Director

4.8

40,000 users